NEW YORK (
) is trading at unusually high volume Tuesday with 27 million shares changing hands. It is currently at four times its average daily volume and trading up $2.37 (+6.5%) at $38.63 as of 3:40 p.m. ET.
Gilead Sciences has a market cap of $29.96 billion and is part of the
industry. Shares are up 0.1% year to date as of the close of trading on Monday.
Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. The company has a P/E ratio of 11.6, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Gilead Sciences as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, increase in net income and attractive valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full
See all heavy volume stocks in our
or get investment ideas from our
Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting
to 95370 or select from